Pages that link to "Q28366792"
Jump to navigation
Jump to search
The following pages link to EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG (Q28366792):
Displaying 50 items.
- Structure and kinetic investigation of Streptococcus pyogenes family GH38 alpha-mannosidase (Q21091150) (← links)
- Viable group A streptococci in macrophages during acute soft tissue infection (Q25257256) (← links)
- Localization-triggered bacterial pathogenesis (Q26781951) (← links)
- Inflammatory etiopathogenesis of systemic lupus erythematosus: an update (Q26796413) (← links)
- Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms (Q27314948) (← links)
- Solution Structure and Backbone Dynamics of Streptopain: INSIGHT INTO DIVERSE SUBSTRATE SPECIFICITY (Q27653912) (← links)
- Ultrahigh and High Resolution Structures and Mutational Analysis of Monomeric Streptococcus pyogenes SpeB Reveal a Functional Role for the Glycine-rich C-terminal Loop (Q27679343) (← links)
- Crystal structure of Streptococcus pyogenes EndoS, an immunomodulatory endoglycosidase specific for human IgG antibodies (Q27683509) (← links)
- Structure and activity of the Streptococcus pyogenes family GH1 6-phospho-β-glucosidase SPy1599 (Q27683662) (← links)
- Treatment of neuromyelitis optica: state-of-the-art and emerging therapies (Q28245749) (← links)
- Global Analysis and Comparison of the Transcriptomes and Proteomes of Group A Streptococcus Biofilms (Q28395982) (← links)
- Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis (Q28471918) (← links)
- Optimal Synthetic Glycosylation of a Therapeutic Antibody (Q28831266) (← links)
- Optimal Synthetic Glycosylation of a Therapeutic Antibody (Q28831364) (← links)
- Vaccination against the M protein of Streptococcus pyogenes prevents death after influenza virus: S. pyogenes super-infection. (Q30586381) (← links)
- IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. (Q30829613) (← links)
- Phylogenomic analysis of natural selection pressure in Streptococcus genomes (Q30833778) (← links)
- Immune-Signatures for Lung Cancer Diagnostics: Evaluation of Protein Microarray Data Normalization Strategies (Q31126986) (← links)
- EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity (Q33313641) (← links)
- IdeS: a bacterial proteolytic enzyme with therapeutic potential (Q33321259) (← links)
- IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions (Q33378924) (← links)
- SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines (Q33416426) (← links)
- A combination of independent transcriptional regulators shapes bacterial virulence gene expression during infection (Q33545217) (← links)
- The M protein is dispensable for maturation of streptococcal cysteine protease SpeB. (Q33793995) (← links)
- Study of the IgG endoglycosidase EndoS in group A streptococcal phagocyte resistance and virulence (Q33914405) (← links)
- The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis (Q33931736) (← links)
- The N-glycan Glycoprotein Deglycosylation Complex (Gpd) from Capnocytophaga canimorsus Deglycosylates Human IgG (Q33954405) (← links)
- Efficient utilization of complex N-linked glycans is a selective advantage for Bacteroides fragilis in extraintestinal infections (Q34144466) (← links)
- The Enterococcus faecalis exoproteome: identification and temporal regulation by Fsr. (Q34200965) (← links)
- Cysteine proteinase SpeB from Streptococcus pyogenes – a potent modifier of immunologically important host and bacterial proteins (Q34229809) (← links)
- Disruption of the Eng18B ENGase gene in the fungal biocontrol agent Trichoderma atroviride affects growth, conidiation and antagonistic ability (Q34269078) (← links)
- The role of complex carbohydrate catabolism in the pathogenesis of invasive streptococci (Q34286655) (← links)
- Proteolysis and its regulation at the surface of Streptococcus pyogenes (Q34585533) (← links)
- Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes (Q34762884) (← links)
- EndoS reduces the pathogenicity of anti-mCOL7 IgG through reduced binding of immune complexes to neutrophils (Q35087854) (← links)
- EndoE from Enterococcus faecalis hydrolyzes the glycans of the biofilm inhibiting protein lactoferrin and mediates growth (Q35114449) (← links)
- Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes (Q35133183) (← links)
- IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis. (Q35153201) (← links)
- The N-Glycan cluster from Xanthomonas campestris pv. campestris: a toolbox for sequential plant N-glycan processing (Q35172891) (← links)
- Relative quantitation of glycopeptides based on stable isotope labeling using MALDI-TOF MS. (Q35204455) (← links)
- Bacterial glycosidases in pathogenesis and glycoengineering. (Q35362348) (← links)
- EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans (Q35686671) (← links)
- Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities (Q35705039) (← links)
- Remarkable transglycosylation activity of glycosynthase mutants of endo-D, an endo-β-N-acetylglucosaminidase from Streptococcus pneumoniae. (Q35879412) (← links)
- A common glycan structure on immunoglobulin G for enhancement of effector functions (Q36008257) (← links)
- Microscale purification of antigen-specific antibodies (Q36157114) (← links)
- CP40 from Corynebacterium pseudotuberculosis is an endo-β-N-acetylglucosaminidase. (Q36184582) (← links)
- Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions. (Q36189447) (← links)
- Antiphagocytic function of an IgG glycosyl hydrolase from Streptococcus equi subsp. equi and its use as a vaccine component (Q36211146) (← links)
- Endo-β-N-acetylglucosaminidases from infant gut-associated bifidobacteria release complex N-glycans from human milk glycoproteins. (Q36211809) (← links)